MedPath

万邦德制药集团有限公司

Ownership
-
Established
2002-07-29
Employees
-
Market Cap
-
Website
https://www.wanbang.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

204

NMPA:204

Drug Approvals

Cefaclor Granules

Product Name
头孢克洛颗粒
Approval Number
国药准字H20258001
Approval Date
Jan 2, 2025
NMPA

Pediatric Paracetamol,Atificial Cow-bezoar and Chlorphenamine Maleate Granules

Product Name
小儿氨酚黄那敏颗粒
Approval Number
国药准字H13023772
Approval Date
Sep 30, 2024
NMPA

Dioxopromethazine Hydrochloride Tablets

Product Name
盐酸二氧丙嗪片
Approval Number
国药准字H13024113
Approval Date
Sep 25, 2024
NMPA

Ibuprofen Tablets

Product Name
布洛芬片
Approval Number
国药准字H13022258
Approval Date
Sep 25, 2024
NMPA

Compound Diclofenac Sodium Chlorphenamine Maleate Tablets

Product Name
氯芬黄敏片
Approval Number
国药准字H13023767
Approval Date
Sep 25, 2024
NMPA

Aminopyrine and Caffeine Tablets

Product Name
氨基比林咖啡因片
Approval Number
国药准字H13024055
Approval Date
Sep 25, 2024
NMPA

Xanthinol Nicotinate Tablets

Product Name
烟酸占替诺片
Approval Number
国药准字H13023773
Approval Date
Sep 20, 2024
NMPA

Piracetam Tablets

Product Name
吡拉西坦片
Approval Number
国药准字H13022245
Approval Date
Sep 14, 2024
NMPA

Galculus Bovis and Metronidazole Capsules

Product Name
人工牛黄甲硝唑胶囊
Approval Number
国药准字H13023770
Approval Date
Sep 14, 2024
NMPA

Doxycycline Hyclate Tablets

Product Name
盐酸多西环素片
Approval Number
国药准字H13022241
Approval Date
Sep 14, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 21
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.